Bronson Crouch - 08 Jan 2023 Form 4 Insider Report for Instil Bio, Inc. (TIL)

Reporting relationship: CEO and Chairman, Director, 10%+ Owner
Issuer ticker: TIL
Reported as of: 08 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Jan 2023, 15:09:25 UTC
Prior SEC filing: 20 Jan 2023
Next SEC filing: 13 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ Sandeep Laumas, M.D. Attorney-in-Fact for Bronson Crouch

Key filing fact

Bronson Crouch filed Form 4 for Instil Bio, Inc. (TIL) on 20 Jan 2023.

Key facts

This page summarizes Bronson Crouch's Form 4 filing for Instil Bio, Inc. (TIL).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 20 Jan 2023, 15:09.

Change

Previous filing in this sequence was filed on 20 Jan 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TIL transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value: $0
Shares: +1,000,000
Change %
Price: $0.000000
Shares after: 1,000,000
Date: 08 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,000,000
Exercise price: $0.6340
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Twenty-five percent (25%) of the shares subject to the option vest on January 8, 2024, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.